Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eishi Baba

Showing results (131-140 of 189) with videos related to

Pageof 19
Sort By:
Cancer Science|September 7, 2018
PD-1+ TIM-3+ T cells in malignant ascites predict prognosis of gastrointestinal cancerMichitaka Nakano, Mamoru Ito, Risa Tanaka, et al.
JCO Precision Oncology|May 15, 2024
Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced Gastric CancerKyoko Yamaguchi, Mamoru Ito, Taichi Isobe, et al.
Eclinicalmedicine|February 9, 2024
Dabrafenib and trametinib administration in patients with <i>BRAF</i> V600E/R or non-V600 <i>BRAF</i> mutated advanced solid tumours (BELIEVE, NCCH1901): a multicentre, open-label, and single-arm phase II trialTatsunori Shimoi, Kuniko Sunami, Makoto Tahara, et al.
Scientific Reports|February 3, 2021
Predictive impact of C-reactive protein to albumin ratio for recurrent or metastatic head and neck squamous cell carcinoma receiving nivolumabKenro Tanoue, Shingo Tamura, Hitoshi Kusaba, et al.
Medicine|October 14, 2018
Metastatic esophageal carcinosarcoma comprising neuroendocrine carcinoma, squamous cell carcinoma, and sarcoma: A case reportKenji Tsuchihashi, Shuji Arita, Minako Fujiwara, et al.
FEBS Open Bio|November 19, 2019
Methylation of drug resistance-related genes in chemotherapy-sensitive Epstein-Barr virus-associated gastric cancerHirofumi Ohmura, Mamoru Ito, Keita Uchino, et al.
Anti-Cancer Drugs|September 15, 2017
Early tumor shrinkage indicates a favorable response to bevacizumab-based first-line chemotherapy for metastatic colorectal cancerMamoru Ito, Hitoshi Kusaba, Satomi Mukaide, et al.
Cancer Medicine|December 4, 2020
Comprehensive molecular profiling broadens treatment options for breast cancer patientsHitomi Kawaji, Makoto Kubo, Nami Yamashita, et al.
Anticancer Research|May 7, 2017
Efficacy and Safety Analysis of Oxaliplatin-based Chemotherapy for Advanced Gastric CancerKyoko Inadomi, Hitoshi Kusaba, Yuzo Matsushita, et al.
Esophagus : Official Journal of the Japan Esophageal Society|October 29, 2025
Safety and efficacy of conversion therapy for metastatic esophageal cancer: exploratory analysis of JCOG1314Satoru Matsuda, Takahiro Tsushima, Hirofumi Kawakubo, et al.
Pageof 19

Showing results (131-140 of 189) with videos related to

Sort By:
Pageof 19
Cancer Science|September 7, 2018
PD-1+ TIM-3+ T cells in malignant ascites predict prognosis of gastrointestinal cancerMichitaka Nakano, Mamoru Ito, Risa Tanaka, et al.
JCO Precision Oncology|May 15, 2024
Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced Gastric CancerKyoko Yamaguchi, Mamoru Ito, Taichi Isobe, et al.
Eclinicalmedicine|February 9, 2024
Dabrafenib and trametinib administration in patients with <i>BRAF</i> V600E/R or non-V600 <i>BRAF</i> mutated advanced solid tumours (BELIEVE, NCCH1901): a multicentre, open-label, and single-arm phase II trialTatsunori Shimoi, Kuniko Sunami, Makoto Tahara, et al.
Scientific Reports|February 3, 2021
Predictive impact of C-reactive protein to albumin ratio for recurrent or metastatic head and neck squamous cell carcinoma receiving nivolumabKenro Tanoue, Shingo Tamura, Hitoshi Kusaba, et al.
Medicine|October 14, 2018
Metastatic esophageal carcinosarcoma comprising neuroendocrine carcinoma, squamous cell carcinoma, and sarcoma: A case reportKenji Tsuchihashi, Shuji Arita, Minako Fujiwara, et al.
FEBS Open Bio|November 19, 2019
Methylation of drug resistance-related genes in chemotherapy-sensitive Epstein-Barr virus-associated gastric cancerHirofumi Ohmura, Mamoru Ito, Keita Uchino, et al.
Anti-Cancer Drugs|September 15, 2017
Early tumor shrinkage indicates a favorable response to bevacizumab-based first-line chemotherapy for metastatic colorectal cancerMamoru Ito, Hitoshi Kusaba, Satomi Mukaide, et al.
Cancer Medicine|December 4, 2020
Comprehensive molecular profiling broadens treatment options for breast cancer patientsHitomi Kawaji, Makoto Kubo, Nami Yamashita, et al.
Anticancer Research|May 7, 2017
Efficacy and Safety Analysis of Oxaliplatin-based Chemotherapy for Advanced Gastric CancerKyoko Inadomi, Hitoshi Kusaba, Yuzo Matsushita, et al.
Esophagus : Official Journal of the Japan Esophageal Society|October 29, 2025
Safety and efficacy of conversion therapy for metastatic esophageal cancer: exploratory analysis of JCOG1314Satoru Matsuda, Takahiro Tsushima, Hirofumi Kawakubo, et al.
Pageof 19